Literature DB >> 20589487

Diagnosis and prognosis of coronary artery disease: PET is superior to SPECT: Pro.

Rob S B Beanlands1, George Youssef.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20589487     DOI： 10.1007/s12350-010-9253-z

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  53 in total

1.  Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants.

Authors: 
Journal:  Lancet       Date:  1997-08-16       Impact factor: 79.321

2.  Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects.

Authors:  R C Brunken; F V Mody; R A Hawkins; C Nienaber; M E Phelps; H R Schelbert
Journal:  Circulation       Date:  1992-11       Impact factor: 29.690

3.  Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease.

Authors:  Ricardo C Cury; Cesar A M Cattani; Luiz A G Gabure; Douglas J Racy; Jose M de Gois; Uwe Siebert; Sergio S Lima; Thomas J Brady
Journal:  Radiology       Date:  2006-07       Impact factor: 11.105

4.  Impact of myocardial perfusion imaging with PET and (82)Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management.

Authors:  Michael E Merhige; William J Breen; Victoria Shelton; Teresa Houston; Brian J D'Arcy; Anthony F Perna
Journal:  J Nucl Med       Date:  2007-07       Impact factor: 10.057

5.  A retrospective study of the diagnostic accuracy of a community hospital-based PET center for the detection of coronary artery disease using rubidium-82.

Authors:  B R Williams; N A Mullani; D E Jansen; B A Anderson
Journal:  J Nucl Med       Date:  1994-10       Impact factor: 10.057

6.  CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease--executive summary.

Authors:  R S B Beanlands; B J W Chow; A Dick; M G Friedrich; K Y Gulenchyn; M Kiess; H Leong-Poi; R M Miller; G Nichol; M Freeman; P Bogaty; G Honos; G Hudon; G Wisenberg; J Van Berkom; K Williams; K Yoshinaga; J Graham
Journal:  Can J Cardiol       Date:  2007-02       Impact factor: 5.223

7.  F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).

Authors:  Rob S B Beanlands; Graham Nichol; Ella Huszti; Dennis Humen; Normand Racine; Michael Freeman; Karen Y Gulenchyn; Linda Garrard; Robert deKemp; Ann Guo; Terrence D Ruddy; Francois Benard; André Lamy; Robert M Iwanochko
Journal:  J Am Coll Cardiol       Date:  2007-10-10       Impact factor: 24.094

Review 8.  Clinical myocardial perfusion PET/CT.

Authors:  Marcelo F Di Carli; Sharmila Dorbala; Jolene Meserve; Georges El Fakhri; Arkadiusz Sitek; Stephen C Moore
Journal:  J Nucl Med       Date:  2007-05       Impact factor: 10.057

9.  Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease.

Authors:  R E Patterson; R L Eisner; S F Horowitz
Journal:  Circulation       Date:  1995-01-01       Impact factor: 29.690

10.  Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease.

Authors:  Kirkeith Lertsburapa; Alan W Ahlberg; Timothy M Bateman; Deborah Katten; Lyndy Volker; S James Cullom; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2008-09-12       Impact factor: 5.952
View more
  7 in total

1.  Nuclear cardiology in the present and beyond: can we meet the challenges?

Authors:  Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-05-25       Impact factor: 5.952

Review 2.  Assessment of coronary endothelial function using PET.

Authors:  Keiichiro Yoshinaga; Osamu Manabe; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952

Review 3.  SPECT imaging for detecting coronary artery disease and determining prognosis by noninvasive assessment of myocardial perfusion and myocardial viability.

Authors:  George A Beller; Ruth C Heede
Journal:  J Cardiovasc Transl Res       Date:  2011-07-06       Impact factor: 4.132

4.  CT fractional flow reserve: the next level in non-invasive cardiac imaging.

Authors:  M F L Meijs; M J Cramer; H El Aidi; P A Doevendans
Journal:  Neth Heart J       Date:  2012-10       Impact factor: 2.380

Review 5.  Role of Cardiac PET in Clinical Practice.

Authors:  Brian M Salata; Parmanand Singh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-11-09

Review 6.  Diagnosing coronary artery disease with hybrid PET/CT: it takes two to tango.

Authors:  Ibrahim Danad; Pieter G Raijmakers; Paul Knaapen
Journal:  J Nucl Cardiol       Date:  2013-10       Impact factor: 5.952

Review 7.  Mitochondrial-Targeted Molecular Imaging in Cardiac Disease.

Authors:  Jinhui Li; Jing Lu; You Zhou
Journal:  Biomed Res Int       Date:  2017-05-30       Impact factor: 3.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.